According to Trinity Biotech 's latest financial reports and stock price the company's current number of shares outstanding is 7,665,514. At the end of 2023 the company had 7,665,514 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 7.66 M | 0.58% |
2022 | 7.62 M | 82.32% |
2021 | 4.18 M | 0% |
2020 | 4.18 M | 0% |
2019 | 4.18 M | 0% |
2018 | 4.18 M | -1.08% |
2017 | 4.22 M | -7.17% |
2016 | 4.55 M | -2.14% |
2015 | 4.65 M | 1.5% |
2014 | 4.58 M | 2.94% |
2013 | 4.45 M | 3.65% |
2012 | 4.29 M | 0.84% |
2011 | 4.25 M | 0.54% |
2010 | 4.23 M | 1.15% |
2009 | 4.18 M | 0.43% |
2008 | 4.17 M | 9.71% |
2007 | 3.8 M | 2.76% |
2006 | 3.69 M | 24.57% |
2005 | 2.97 M | 323.62% |
2004 | 0.7 M | 28.18% |
2003 | 0.54 M | 7.82% |
2002 | 0.5 M | 0.42% |
2001 | 0.5 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 1,734,076,358 | 22,521.79% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | 387,000,000 | 4,948.59% | ๐บ๐ธ USA |
Danaher DHR | 740,600,000 | 9,561.45% | ๐บ๐ธ USA |
QuidelOrtho QDEL | 66,900,000 | 772.74% | ๐บ๐ธ USA |
OraSure Technologies OSUR | 73,499,000 | 858.83% | ๐บ๐ธ USA |
Chembio Diagnostics CEMI | 32,274,664 | 321.04% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | 29,102,000 | 279.65% | ๐บ๐ธ USA |